Keyphrases
Adjusted Analysis
8%
Adjusted Rates
8%
Anemia
8%
Anticoagulants
8%
Antiplatelet Agents
8%
Bleeding
100%
Clinical Trials
8%
Confidence Interval
8%
Critically Ill Patients
100%
Hazard Ratio
8%
High-risk Population
8%
Intensive Care Unit
25%
Major Bleeding
41%
Major Bleeding Events
8%
Methods Observational
8%
Minor Bleeding
8%
Minor Uses
8%
Observational Cohort Study
8%
Platelet Increment
16%
Platelet Transfusion
100%
Posttransfusion
16%
Potential Harm
8%
Product Type
8%
Thrombocytopenia
100%
Thromboprophylaxis
8%
Thrombosis
16%
Timing of Administration
8%
Transfusion Hazards
8%
Medicine and Dentistry
Anemia
7%
Anticoagulant
7%
Antiplatelet Drug
7%
Bleeding
100%
Clinical Trial
7%
Cohort Study
7%
Hazard Ratio
7%
Hemostat
7%
High Risk Population
7%
Intensive Care Unit
23%
Major Bleeding
38%
Platelet
7%
Thrombocyte Transfusion
100%
Thrombocytopenia
100%
Thromboprophylaxis
7%
Thrombosis
15%